Novartis has acquired US-based clinical-stage biopharmaceutical company Chinook Therapeutics for up to $3.5bn upfront.
14 Aug 2023
17 Jul 2023
The US Food and Drug Administration (FDA) has granted clearance to Gilead Sciences’ supplemental new drug application (sNDA) of Veklury (remdesivir) for use in Covid-19 patients.
26 Jun 2023
Medicines Patent Pool (MPP), a UN-supported international public health organisation, has signed seven sublicence agreements for Japanese pharmaceutical firm Shionogi & Co's Ensitrelvir fumaric acid.
24 May 2023
Innoviva Specialty Therapeutics has received approval from the US Food and Drug Administration (FDA) for XACDURO to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP).
21 Feb 2023
The US Food and Drug Administration (FDA) has finished a filing review of Valneva’s Biologics License Application (BLA) for single-shot chikungunya vaccine candidate VLA1553.
13 Jan 2023
Daiichi Sankyo has submitted an application to the regulatory authorities in Japan seeking marketing approval of DS-5670.
10 Nov 2022
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given approval to Beyfortus (nirsevimab) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season.
25 Aug 2022
Bavarian Nordic has signed a supply agreement with the Pan American Health Organization (PAHO) for its monkeypox vaccine.
22 Jul 2022
Bharat Biotech International Limited (BBIL) has announced that its whole-virion inactivated COVID-19 vaccine, BBV152 (COVAXIN), has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
03 May 2022
Intravacc has signed an exclusive licensing agreement with Beijing Zhifei Lvzhu Biopharmaceutical (Zhifei Lvzhu) in China for Avacc 3, an OMV-based whooping cough vaccine.